Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations

Anjelica Hodgson, Bas W.G. van Rhijn, Sung Sun Kim, Colleen Ding, Rola Saleeb, Danny Vesprini, Stanley K. Liu, George M. Yousef, Theodorus van der Kwast, Bin Xu, Michelle R. Downes